Defunct Company
Total Trials
17
As Lead Sponsor
As Collaborator
0
Total Enrollment
3,742
NCT00466791
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2004
Completion: May 31, 2005
NCT00444574
Safety and Efficacy of MTS Versus Concerta in Pediatric Patients (Aged 6-12 Years) With ADHD
Phase: Phase 3
Start: Sep 30, 2004
Completion: Jun 30, 2005
NCT00151957
Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials
Start: Oct 31, 2004
Completion: Jun 30, 2007
NCT00151970
Efficacy, Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD
Start: Jun 30, 2005
Completion: Oct 31, 2006
NCT00151983
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
Completion: Jul 31, 2006
NCT00434213
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
Phase: Phase 4
Start: Jan 31, 2007
Completion: Jul 31, 2008
NCT00499863
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
Start: Jul 31, 2007
Completion: May 31, 2008
NCT00501293
Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
Start: Aug 31, 2007
Completion: Feb 28, 2009
NCT00786188
Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause
Start: Nov 30, 2008
Completion: Jun 30, 2009
NCT01101841
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms
Start: Mar 31, 2010
Completion: Nov 30, 2011
NCT01361308
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)
Start: May 31, 2011
Completion: Feb 29, 2012
NCT01829919
Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women
Phase: Phase 1
Start: Jul 31, 2011
Completion: Aug 31, 2011
NCT04094025
Irritation and Sensitization Study of d-Amphetamine Transdermal System
Start: Dec 2, 2019
Completion: May 16, 2020
NCT05656573
CART-PSMA Cells for Advanced Prostate Cancer
Start: Mar 1, 2023
Completion: Dec 1, 2025
NCT06531486
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors
Phase: Phase 1/2
Start: Jul 29, 2024
Completion: Aug 30, 2027
NCT06820268
A Study of XS-04 in Patients with Relapsed or Refractory Hematologic Malignancies
Start: Jan 14, 2025
Completion: Mar 15, 2028
NCT06936527
XS-03 in Combination With FOLFOX or FOLFIRI and Bevacizumab for Treatment of Metastatic Colorectal Cancer Patients With RAS Mutation
Start: May 23, 2025
Completion: Jul 30, 2028